ESC Forum on Drug Eluting Stents European Heart
نویسندگان
چکیده
Authors/writing members: Joost Daemen1, Maarten L. Simoons1, William Wijns2, Adrian Bagust3, Gert Bos4, James M. Bowen5, Eugene Braunwald6, Edoardo Camenzind7, Bernard Chevalier8, Carlo DiMario9, Jean Fajadet10, Anselm Gitt11, Giulio Guagliumi12, Hans L. Hillege13, Stefan James14, Peter Jüni15, Adnan Kastrati16, Sabine Kloth17, Steen D. Kristensen18, Mitchell Krucoff19, Victor Legrand20, Matthias Pfisterer21, Martin Rothman22, Patrick W. Serruys1, Sigmund Silber23, Philippe G. Steg24, Ibrahim Tariah25, Lars Wallentin14, and Stephan W. Windecker26
منابع مشابه
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.
Authors/writing members: Joost Daemen1, Maarten L. Simoons1, William Wijns2, Adrian Bagust3, Gert Bos4, James M. Bowen5, Eugene Braunwald6, Edoardo Camenzind7, Bernard Chevalier8, Carlo DiMario9, Jean Fajadet10, Anselm Gitt11, Giulio Guagliumi12, Hans L. Hillege13, Stefan James14, Peter Jüni15, Adnan Kastrati16, Sabine Kloth17, Steen D. Kristensen18, Mitchell Krucoff19, Victor Legrand20, Matthi...
متن کاملReport of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary.
The evaluation for European Union market approval of coronary stents falls under the Medical Device Directive that was adopted in 1993. Specific requirements for the assessment of coronary stents are laid out in supplementary advisory documents. In response to a call by the European Commission to make recommendations for a revision of the advisory document on the evaluation of coronary stents (...
متن کاملImproving patient access to novel medical technologies in Europe.
The European Society of Cardiology (ESC) organized a one-day workshop with clinicians, health economic experts, and health technology appraisal experts to discuss the equity of patient access to novel medical technologies in Europe. Two index technologies were considered: implantable cardioverter defibrillators (ICDs) and drug-eluting stents (DES). The use of ICDs range from 35 implants/million...
متن کاملPerspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization
The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, urgent, and emergency settings. The 2014 document updates and extends the effor...
متن کاملPhysiology-guided myocardial revascularisation in complex multivessel coronary artery disease: beyond the 2014 ESC/EACTS guidelines on myocardial revascularisation
For patients with multivessel coronary artery disease there are two options for revascularisation: Percutaneous coronary intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG). In daily clinical practice, a heart team consisting of an interventional cardiologist and a cardiothoracic surgeon decide on the most appropriate mode of revascularization. The current European guidelines on m...
متن کامل